Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Smokey1958on Jan 08, 2021 7:56am
163 Views
Post# 32252124

Imminent NR???

Imminent NR???

The biggest news from Thrm to date was released in the December 7, 2020 NR.

The following is from the NanoComposix website referring to Covid rapid tests (included in the URL attached).

"nanoComposix is fully equipped to support new lateral flow assay development projects. Our team of experts can help develop an early stage point of care test from concept to prototype in as little as 4 weeks."

Could  today be the day. Is the device now ready for testing. Given that the holiday period would slow things down, next week may be a more likely 4 week target. If anyone thought so before, this is no longer a mirage. Thrm (CoviSafe) is the real deal and the next NR will see this stock soar. We will be looking down on the $.50 high from last summer when this NR is released. 

GLTA!
 


https://nanocomposix.com/pages/sars-cov-2-covid-19-rapid-diagnostic-test-reagents?homebanner

<< Previous
Bullboard Posts
Next >>